| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $15.9M | -7.4% |
| Operating Income | -$16.4M | +66.6% |
| Net Income | -$20.1M | +59.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17K | -96.4% |
| Current Assets | $651K | -72.9% |
| Total Assets | $651K | -95.7% |
| Current Liabilities | $1.0M | -86.1% |
| Total Liabilities | $1.1M | -86.0% |
| Stockholders' Equity | -$401K | -105.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | -14.1% |
| Investing Cash Flow | -$482K | -106.7% |
| Financing Cash Flow | $18.0M | +142.7% |